Native magnetic resonance imaging versus contrast enhanced computed tomography in the diagnosis of acute pulmonary embolism

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004729

Enrollment

Registered

2013-02-18

Start date

2013-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pulmonary embolism I26

Interventions

Group 1: Patients in whose an acute pulmonare embolism is detected in a contrast enhanced computed tomography examination (CE-CT) are included in the study. These patients are offered to undergo a nat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: stable circulation; pulmonary embolism proven in contrast enhanced computed tomography; signed patient consent

Exclusion criteria

Exclusion criteria: contraindications to MRI (pacemaker, claustrophobia, adipositas per magna); pregnancy; unstable circulation; patient unable to give consent; delay of therapy due to MRI examination

Design outcomes

Secondary

Measure	Time frame
Appearance of false positive and false negative results in the native magnetic resonance imaging examination. Comparison of signs of right heart burden (WACKER score) detected by sonography versus magnetic resonance imaging. Survival 28 days.	—

Primary

Measure	Time frame
Comparison of embolus burden detected by contrast enhanced computed tomography (gold standard) versus embolus burden detected by native magnetic resonance imaging. Embolus burden is quantified with the MASTORA score.	—

Countries

Germany

Contacts

Public ContactAndreas Gunter Bach

Universität Halle Medizinische Fakultät

mail@andreas-bach.de0345-5572440

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026